Previous close | 0.7000 |
Open | 0.7000 |
Bid | 0.0000 |
Ask | 1.0000 |
Strike | 150.00 |
Expiry date | 2025-01-17 |
Day's range | 0.7000 - 4.2000 |
Contract range | N/A |
Volume | |
Open interest | 15 |
On May 2, 2024, Director Sangeeta Bhatia sold 467 shares of Vertex Pharmaceuticals Inc (NASDAQ:VRTX) as reported in a recent SEC Filing.
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $400.16, representing a -0.49% change from its previous close.
Arcus Biosciences (RCUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.